Omnicell, Inc.
NASDAQCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Randall A. Lipps
- Full Time Employees
- 3,485
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 4220 North Freeway Fort Worth TX United States of America 76137
- IPO Date
- Aug 7, 2001
- CIK
- 0000926326
- Website
- omnicell.com
- Similar Companies
- Business
- Omnicell, Inc. is a healthcare technology company specializing in medication management solutions and adherence tools designed to enhance healthcare delivery and operational efficiency. The company offers an extensive portfolio that includes automated medication dispensing systems; pharmacy automation equipment; medication adherence packaging; analytics and inventory management software; point-of-care pharmacy automation; adherence packaging systems under the MyMD packaging brand; and clinical decision support applications. Omnicell serves healthcare providers, pharmacies, hospitals, and long-term care facilities across the United States, Canada, and select international markets. Founded in 1992, the company is headquartered in Mountain View, California. In the past 1-2 years, Omnicell has focused on expanding its clinical and financial analytics capabilities, integrating new software enhancements to improve medication safety and operational workflows. The company has also been active in strategic partnerships that broaden its technology ecosystem and has launched updated versions of its adherence packaging solutions. Omnicell continues to extend its presence in the pharmacy automation market through selective acquisitions and innovation in medication management systems. These initiatives reflect a strategic shift toward comprehensive service offerings that combine hardware, software, and analytics to support a data-driven approach in healthcare operations. Omnicell operates primarily in the healthcare technology and medical devices industry, targeting hospital systems, health systems, retail pharmacies, and senior care providers. Its product and service offerings are designed to address challenges in medication adherence, reduce medication errors, optimize pharmacy workflows, and improve patient outcomes. The company maintains a broad geographic footprint across North America with growing influence internationally, supported by its network of subsidiaries and partners specializing in healthcare technology solutions.
Company News
Is This the Right Time to Retain Omnicell Stock in Your Portfolio?
Financial Contrast: Baxter International (NYSE:BAX) and Omnicell (NASDAQ:OMCL)
Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026
Omnicell (OMCL) is a Top-Ranked Value Stock: Should You Buy?
Here's Why Omnicell (OMCL) is a Strong Value Stock
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
Omnicell President Sells 6,753 Shares
Bank of America Corp DE Has $19.39 Million Position in Omnicell, Inc. $OMCL
Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins
OMCL Falls 20.1% in a Month as Booking and Margin Risks Build
Here's Why Omnicell (OMCL) is a Strong Value Stock
Is Omnicell Inc (OMCL) a Bargain After 4.7% Drop? GF Value Says Undervalued
OMCL Q2 Earnings Call Highlights Titan XT Pipeline Growth
Dimensional Fund Advisors LP Acquires 137,834 Shares of Omnicell, Inc. $OMCL
EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination
Omnicell Q2 Earnings Call Highlights
Omnicell, Inc. (OMCL) Q2 2026 Earnings Call Transcript
Omnicell (OMCL) Q2 Earnings and Revenues Top Estimates